ArticleJournal of molecular medicine (Berlin, Germany)2026

MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC.

Ling-Ming Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.